As the Maly IT team, we understand the benefits of adopting good practices in the pharmaceutical industry. Ever mindful that the health and well-being of individuals depends on the quality, safety, and efficacy of medicinal products. Therefore, we agree that helping our customers to assure adherence to stringent guidelines and regulations is paramount. What are […]
Artificial Intelligence (AI) is up ending the recruitment business model, automating everything from sourcing and screening to candidate engagement and assessment. However, as we saw in Part 1 organisations embracing these tools must also navigate an increasingly complex web of regulations and ethical standards. The use of AI in recruitment significantly impacts compliance with laws
Recruitment is the gateway to every organisation’s talent and culture. But in today’s regulatory landscape, it’s not enough to simply find the right candidate; you must do so within a framework of strict compliance. This is becoming more complex than ever, especially as organisations increasingly rely on contractors and freelancers. Navigating this landscape requires not
Our regular readers will know Maly is a company which specialises in helping innovators simplify, digitise, automate and control complex industrial and compliance processes. The Okuda no-code tool allows users to model and capture any process as a series of simple digital steps, ensuring each individual and team plays their part at the right time
Building upon Part 1’s exploration of product labelling as a defence against counterfeiting, this article (Part 2) delves into the intricate process of managing pharmaceutical labelling changes, crucial for compliance, minimising waste, and maintaining efficient supply chains across multiple markets. The seemingly simple act of changing a word or updating a logo on a pharmaceutical
The ability to visually and digitally verify a product is genuine, is a vital part of the combat against counterfeit products, argues Richard Maly. In the high-stakes realm of biotechnology and pharmaceuticals, where precision and patient safety are paramount, product labelling transcends mere information provision. It becomes a critical line of defence against the insidious
You may have missed this news headline amongst all of the global upheaval we’ve been bombarded with recently. This was yet another eye-opening and serious example of what can go catastrophically wrong if your business suffers a process compliance failure. Somehow 110,000 packs of Boots medication (Paracetamol in this case) reached the shop shelves with
The pharmaceutical industry thrives on trust. Patients and healthcare professionals rely on the safety and efficacy of your drugs. Our proven experience in GxP compliance can be a powerful asset for your business, ensuring you meet the highest standards throughout the entire product lifecycle. GxP: The Foundation of Quality GxP stands for Good x Practice, where “x” represents specific
Process compliance is crucial in new drug development and testing as it ensures that all regulatory requirements are met at each stage, from discovery to post-marketing surveillance. Compliance involves rigorous scientific research, data integrity, and adherence to Good Manufacturing Practices (GMP) and regulatory submissions such as the Clinical Trial Application (CTA) (Investigational New Drug –
In recent years we’ve seen the number of news stories soar where a well-known company brand is fined for a breach of regulations or lack of compliance with an industry standard. Some of the fines are eye watering and yet it’s the reputational damage and negative press that seem to dismay shareholders the most and
